DermTech, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2017 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
DermTech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2017 to Q1 2024.
  • DermTech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $122K, a 86.7% decline year-over-year.
  • DermTech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $6.08M, a 563% increase from 2022.
  • DermTech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $917K, a 99.6% decline from 2021.
  • DermTech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $230M, a 192% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $122K -$794K -86.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $916K +$389K +73.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $527K -$205M -99.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $205M +$145M +241% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q1 2020 $60.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q2 2019 $10.5K* +$10.5K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-13
Q2 2018 $0 -$146M -100% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q2 2017 $146M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.